A pill set to help drinkers curb their cravings will be made available to NHS patients in England.
The Nalmafene drug has been specialized for those who are dependent on alcohol.
Estimates suggest alcohol-related harm costs the NHS 3.5 billion pounds a year.
Dr David Collier, Joint Clinical Director for the William Harvey Research Institute Clinical Research Centre at the Queen Mary University Hospital, joined Wake Up London to discuss his new alcohol research and the difficulties he experienced with it.
He was part of the team who ran the trials for the drug that NICE are now recommending for use in England and is already used in Scotland.
He spoke about the trail, gave details of his research and explained why it was so difficult it was to get the new drug approved.